Or. Admin. Code § 333-333-2120 - Psilocybin Product Delivery Methods
(1) A manufacturer must design and manufacture all psilocybin products to be consumed by a client orally or delivered via another enteral method
(2) A manufacturer is prohibited from designing or manufacturing psilocybin products that can be delivered to clients through any method other than orally or another enteral method. A manufacturer is prohibited from designing or manufacturing psilocybin products that include but not limited to, transdermal patches, inhalers, nasal sprays, suppositories and injections.
Notes
Statutory/Other Authority: ORS 475A.235
Statutes/Other Implemented: ORS 475A.235
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.